back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-27 13:32 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Quon, Colin
5 - Senior Officer of Issuer
Holder: Connected Displays Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-4,650,726 vol |
516,748 | |
| Filed 2024-03-27 13:31 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Quon, Colin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-225,000 vol |
25,000 | |
| Filed 2024-03-27 13:25 Tx date 2023-11-15 |
$NARA
Pangenomic Health Inc. |
Quon, Colin
5 - Senior Officer of Issuer
Holder: Connected Displays Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$175,040
+3,500,807 vol $0.05 each |
5,167,474 | |
| Filed 2024-03-26 16:35 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Gillis, Tammy Renee
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-337,500
-225,000 vol $1.50 each |
25,000 | |
| Filed 2024-03-25 19:03 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Quon, Colin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-90,000 vol |
10,000 | |
| Filed 2024-03-25 18:59 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Zhang, Kaidong
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-675,000 vol |
75,000 | |
| Filed 2024-03-25 18:58 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Zhang, Kaidong
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-101,250 vol |
11,250 | |
| Filed 2024-03-25 18:56 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Marissen, Maryam
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-900,000 vol |
100,000 | |
| Filed 2024-03-25 18:50 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,350,000 vol |
150,000 | |
| Filed 2024-03-25 18:49 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,730,001 vol |
303,333 | |
| Filed 2024-03-25 18:38 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-571,480 vol |
63,498 | |
| Filed 2024-03-25 18:37 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: Stanlark Ventures Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-594,000 vol |
66,000 | |
| Filed 2024-03-25 18:36 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-360,000 vol |
40,000 | |
| Filed 2024-03-25 18:18 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,350,000 vol |
150,000 | |
| Filed 2024-03-25 18:16 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: ETC3 Holdings Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-360,000 vol |
40,000 | |
| Filed 2024-03-25 18:11 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,935,000 vol |
215,000 | |
| Filed 2024-03-25 17:25 Tx date 2024-02-06 |
$NARA
Pangenomic Health Inc. |
Zhang, Kaidong
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,650
-137,500 vol $0.012 each |
112,500 | |
| Filed 2024-02-21 16:30 Tx date 2024-02-13 |
$NARA
Pangenomic Health Inc. |
Zhang, Kaidong
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19.98
-1,665 vol $0.012 each |
||
| Filed 2024-03-19 14:30 Tx date 2024-03-19 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: ETC3 Holdings Ltd. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
$-150,000
-500,000 vol $0.30 each |
0 | |
| Filed 2024-03-19 13:57 Tx date 2024-03-19 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
52 - Expiration of options
|
$-66,666.80
-333,334 vol $0.20 each |
1,500,000 | |
| Filed 2024-03-19 12:25 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2024-02-23 17:45 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-23 17:45 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
240,000 | ||
| Filed 2024-02-23 17:44 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: Stanlark Ventures Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
660,000 | ||
| Filed 2024-02-23 17:42 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
634,978 | ||
| Filed 2023-03-21 11:52 Tx date 2023-01-11 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$27,500
+275,000 vol $0.10 each |
3,033,334 | |
| Filed 2023-03-21 11:50 Tx date 2023-01-13 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-22,500
-225,000 vol $0.10 each |
1,833,334 | |
| Filed 2023-03-21 11:47 Tx date 2023-01-11 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-27,500
-275,000 vol $0.10 each |
2,058,334 | |
| Filed 2023-03-21 11:39 Tx date 2023-01-10 |
$NARA
Pangenomic Health Inc. |
Lum, Vincent
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,000
-25,000 vol $0.28 each |
2,758,334 | |
| Filed 2023-03-16 02:31 Tx date 2023-01-02 |
$NARA
Pangenomic Health Inc. |
Mydecine Innovations Group Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,784,250
-15,250,000 vol $0.117 each |
2,750,000 | |
| Filed 2022-12-14 23:59 Tx date 2022-12-09 |
$NARA
Pangenomic Health Inc. |
Mydecine Innovations Group Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
18,000,000 | ||
| Filed 2022-12-14 23:59 Tx date 2022-12-09 |
$NARA
Pangenomic Health Inc. |
Mydecine Innovations Group Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,000,000 | ||
| Filed 2022-12-14 21:21 Tx date 2022-12-09 |
$NARA
Pangenomic Health Inc. |
Bartch, David Joshua
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Mydecine Innovations Group Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
18,000,000 | ||
| Filed 2022-12-14 21:17 Tx date 2022-12-09 |
$NARA
Pangenomic Health Inc. |
Bartch, David Joshua
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Mydecine Innovations Group Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,000,000 | ||
| Filed 2022-09-16 14:03 Tx date 2022-09-06 |
$NARA
Pangenomic Health Inc. |
Marissen, Maryam
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000,000 |